Home/Filings/4/0001562180-25-000505
4//SEC Filing

Humer Kristian 4

Accession 0001562180-25-000505

CIK 0001822462other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:15 PM ET

Size

5.6 KB

Accession

0001562180-25-000505

Insider Transaction Report

Form 4
Period: 2025-01-22
Humer Kristian
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-22$4.37/sh+120,000$524,400120,000 total
    Exercise: $4.37Exp: 2035-01-21Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.

Issuer

Foghorn Therapeutics Inc.

CIK 0001822462

Entity typeother

Related Parties

1
  • filerCIK 0001872280

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:15 PM ET
Size
5.6 KB